Please sign in to your account or sign up for a new account to enter the site
[1] According to the researchers TGF-beta1 induction of angiogenesis requires a rapid and transient apoptotic effect mediated by VEGF/VEGFR2. AHK-Cu, by enhancing levels of the Vascular Endothelial Growth Factor, may possibly activate fibroblasts and endothelial cells
By doing so, it improves metabolism and weight control
Ensuring quality, safety, and effectiveness is vital
This hypothesized VEGF/VEGFR interaction may activate a complex intracellular signaling cascade, which may involve multiple proteins such as phospholipase C, protein kinase C, and the mitogen-activated protein kinases
Third-party tested and 99% purity confirmed by in-house HPLC